Regional Chemotherapy: A Focus on Hepatic Artery Infusion for Colorectal Cancer Liver Metastases

Surgical Oncology Clinics of North America

Volumn 17, Issue 4, 2008, Pages 759-771

  Dizon, Don S ^a,b   Schwartz, Joanna ^a   Kemeny, Nancy ^c  

^a WOMEN AND INFANTS HOSPITAL   (United States)

^b BROWN UNIVERSITY   (United States)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARMUSTINE; CISPLATIN; DEXAMETHASONE; DICHLOROMETHOTREXATE; DOXORUBICIN; FLOXURIDINE; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; MITOMYCIN C; OXALIPLATIN;

ABDOMINAL CRAMP; ALKALINE PHOSPHATASE BLOOD LEVEL; ANOREXIA; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CANCER CHEMOTHERAPY; CANCER REGIONAL CHEMOTHERAPY; CANCER SURVIVAL; CHEMICAL HEPATITIS; CHOLESTASIS; CLINICAL TRIAL; COLORECTAL CANCER; CONTINUOUS INFUSION; COOPERATION; DIARRHEA; DRUG CHOICE; DRUG EFFECT; DRUG EFFICACY; DRUG EXPOSURE; DRUG HALF LIFE; DRUG INFUSION; DRUG RESPONSE; DRUG SAFETY; DRUG WITHDRAWAL; DUODENUM ULCER; FIBROSIS; GASTROINTESTINAL SYMPTOM; HEARTBURN; HEPATIC ARTERY; HEPATIC ARTERY INFUSION; HUMAN; HYPERBILIRUBINEMIA; JAUNDICE; LIVER METASTASIS; LIVER NECROSIS; LIVER TOXICITY; MULTIPLE CYCLE TREATMENT; NECROSIS; OUTCOME ASSESSMENT; PATIENT MONITORING; REVIEW; SCLEROSING CHOLANGITIS; SIDE EFFECT; STOMACH ULCER; SURVIVAL TIME; TREATMENT PLANNING;

ADENOCARCINOMA; ANTINEOPLASTIC AGENTS; CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; CLINICAL TRIALS AS TOPIC; COLORECTAL NEOPLASMS; HUMANS; LIVER NEOPLASMS;

EID: 49849101475     PISSN: 10553207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.soc.2008.04.009     Document Type: Review

References (52)

1. Cancer facts & figures 2007. American Cancer Society. Available at:. http://www.cancer.org/downloads/STT/CAFF2007PWSecured.pdf Accessed October 16, 2007
2. de Brauw L.M., van de Velde C.J., Bouwhuis-Hoogerwerf M.L., et al. Diagnostic evaluation and survival analysis of colorectal cancer patients with liver metastases. J Surg Oncol 34 2 (1987) 81-86
3. Bengtsson G., Carlsson G., Hafstrom L., et al. Natural history of patients with untreated liver metastases from colorectal cancer. Am J Surg 141 5 (1981) 586-589
4. Wood C.B., Gillis C.R., and Blumgart L.H. A retrospective study of the natural history of patients with liver metastases from colorectal cancer. Clin Oncol 2 3 (1976) 285-288
5. Stangl R., Altendorf-Hofmann A., Charnley R.M., et al. Factors influencing the natural history of colorectal liver metastases. Lancet 343 8910 (1994) 1405-1410
6. Nordlinger B., Guiguet M., Vaillant J.C., et al. Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Francaise de Chirurgie. Cancer 77 7 (1996) 1254-1262
7. Fong Y., Fortner J., Sun R.L., et al. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 230 3 (1999) 309-318 [discussion: 318-21]
8. Chen H.S., and Gross J.F. Intra-arterial infusion of anticancer drugs: theoretic aspects of drug delivery and review of responses. Cancer Treat Rep 64 1 (1980) 31-40
9. Collins J.M. Pharmacologic rationale for regional drug delivery. J Clin Oncol 2 5 (1984) 498-504
10. Ensminger W.D. Intrahepatic arterial infusion of chemotherapy: pharmacologic principles. Semin Oncol 29 2 (2002) 119-125
11. Eckman W.W., Patlak C.S., and Fenstermacher J.D. A critical evaluation of the principles governing the advantages of intra-arterial infusions. J Pharmacokinet Biopharm 2 3 (1974) 257-285
12. Markman M. Principles of regional antineoplastic drug delivery. In: Markman M. (Ed). Regional chemotherapy: clinical research and practice (2000), Humana Press, Inc.,, Totowa (NJ) 1-4
13. Ensminger W.D., and Gyves J.W. Clinical pharmacology of hepatic arterial chemotherapy. Semin Oncol 10 2 (1983) 176-182
14. Ensminger W.D., Rosowsky A., Raso V., et al. A clinical-pharmacological evaluation of hepatic arterial infusions of 5-fluoro-2′-deoxyuridine and 5-fluorouracil. Cancer Res 38 11 Pt 1 (1978) 3784-3792
15. Dzodic R., Gomez-Abuin G., Rougier P., et al. Pharmacokinetic advantage of intra-arterial hepatic oxaliplatin administration: comparative results with cisplatin using a rabbit VX2 tumor model. Anticancer Drugs 15 6 (2004) 647-650
16. Ducreux M., Ychou M., Laplanche A., et al. Hepatic arterial oxaliplatin infusion plus intravenous chemotherapy in colorectal cancer with inoperable hepatic metastases: a trial of the gastrointestinal group of the Federation Nationale des Centres de Lutte Contre le Cancer. J Clin Oncol 23 22 (2005) 4881-4887
17. van Riel J.M., van Groeningen C.J., Kedde M.A., et al. Continuous administration of irinotecan by hepatic arterial infusion: a phase I and pharmacokinetic study. Clin Cancer Res 8 2 (2002) 405-412
18. van Riel J.M., van Groeningen C.J., de Greve J., et al. Continuous infusion of hepatic arterial irinotecan in pretreated patients with colorectal cancer metastatic to the liver. Ann Oncol 15 1 (2004) 59-63
19. Kemeny N., and Sigurdon E. Intra-arterial chemotherapy for liver tumors. In: Blumgart L. (Ed). Surgery of the liver and biliary tract. 2nd edition (1994), Churchill-Livingstone, New York 1458-1491
20. Allen P.J., Nissan A., Picon A.I., et al. Technical complications and durability of hepatic artery infusion pumps for unresectable colorectal liver metastases: an institutional experience of 544 consecutive cases. J Am Coll Surg 201 1 (2005) 57-65
21. Nonami T., Takeuchi Y., Yasui M., et al. Regional adjuvant chemotherapy after partial hepatectomy for metastatic colorectal carcinoma. Semin Oncol 24 2 Suppl 6 (1997) S6-130-S6-134
22. Curley S.A., Roh M.S., Chase J.L., et al. Adjuvant hepatic arterial infusion chemotherapy after curative resection of colorectal liver metastases. Am J Surg 166 6 (1993) 743-746 [discussion: 746-8]
23. Moriya Y., Sugihara K., Hojo K., et al. Adjuvant hepatic intra-arterial chemotherapy after potentially curative hepatectomy for liver metastases from colorectal cancer: a pilot study. Eur J Surg Oncol 17 5 (1991) 519-525
24. Rudroff C., Altendorf-Hoffmann A., Stangl R., et al. Prospective randomised trial on adjuvant hepatic-artery infusion chemotherapy after R0 resection of colorectal liver metastases. Langenbecks Arch Surg 384 3 (1999) 243-249
25. Kemeny N., Huang Y., Cohen A.M., et al. Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer. N Engl J Med 341 27 (1999) 2039-2048
26. Kemeny N.E., and Gonen M. Hepatic arterial infusion after liver resection. N Engl J Med 352 7 (2005) 734-735
27. Kemeny M.M., Goldberg D., Beatty J.D., et al. Results of a prospective randomized trial of continuous regional chemotherapy and hepatic resection as treatment of hepatic metastases from colorectal primaries. Cancer 57 3 (1986) 492-498
28. Lorenz M., Muller H.H., Schramm H., et al. Randomized trial of surgery versus surgery followed by adjuvant hepatic arterial infusion with 5-fluorouracil and folinic acid for liver metastases of colorectal cancer. German Cooperative on Liver Metastases (Arbeitsgruppe Lebermetastasen). Ann Surg 228 6 (1998) 756-762
29. Kemeny M.M., Adak S., Gray B., et al. Combined-modality treatment for resectable metastatic colorectal carcinoma to the liver: surgical resection of hepatic metastases in combination with continuous infusion of chemotherapy-an intergroup study. J Clin Oncol 20 6 (2002) 1499-1505
30. Tanaka S., Shimada M., Shirabe K., et al. A novel intrahepatic arterial chemotherapy after radical resection for advanced hepatocellular carcinoma. Hepatogastroenterology 52 63 (2005) 862-865
31. Kemeny N., Daly J., Reichman B., et al. Intrahepatic or systemic infusion of fluorodeoxyuridine in patients with liver metastases from colorectal carcinoma. A randomized trial. Ann Intern Med 107 4 (1987) 459-465
32. Hohn D.C., Stagg R.J., Friedman M.A., et al. A randomized trial of continuous intravenous versus hepatic intraarterial floxuridine in patients with colorectal cancer metastatic to the liver: the Northern California Oncology Group trial. J Clin Oncol 7 11 (1989) 1646-1654
33. Chang A.E., Schneider P.D., Sugarbaker P.H., et al. A prospective randomized trial of regional versus systemic continuous 5-fluorodeoxyuridine chemotherapy in the treatment of colorectal liver metastases. Ann Surg 206 6 (1987) 685-693
34. Martin Jr. J.K., O'Connell M.J., Wieand H.S., et al. Intra-arterial floxuridine vs systemic fluorouracil for hepatic metastases from colorectal cancer. A randomized trial. Arch Surg 125 8 (1990) 1022-1027
35. Rougier P., Laplanche A., Huguier M., et al. Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: long-term results of a prospective randomized trial. J Clin Oncol 10 7 (1992) 1112-1118
36. Allen-Mersh T.G., Earlam S., Fordy C., et al. Quality of life and survival with continuous hepatic-artery floxuridine infusion for colorectal liver metastases. Lancet 344 8932 (1994) 1255-1260
37. Lorenz M., and Muller H.H. Randomized, multicenter trial of fluorouracil plus leucovorin administered either via hepatic arterial or intravenous infusion versus fluorodeoxyuridine administered via hepatic arterial infusion in patients with nonresectable liver metastases from colorectal carcinoma. J Clin Oncol 18 2 (2000) 243-254
38. Kerr D.J., McArdle C.S., Ledermann J., et al. Intrahepatic arterial versus intravenous fluorouracil and folinic acid for colorectal cancer liver metastases: a multicentre randomised trial. Lancet 361 9355 (2003) 368-373
39. Naredi P., Oman M., Blind P.J., et al. A comparison between hepatic artery ligation and portal 5-FU infusion versus 5-FU intra arterial infusion for colorectal liver metastases. Eur J Surg Oncol 29 5 (2003) 459-466
40. Reappraisal of hepatic arterial infusion in the treatment of nonresectable liver metastases from colorectal cancer. Meta-Analysis Group in Cancer. J Natl Cancer Inst 88 5 (1996) 252-258
41. Kemeny N.E., Niedzwiecki D., Hollis D.R., et al. Hepatic arterial infusion versus systemic therapy for hepatic metastases from colorectal cancer: a randomized trial of efficacy, quality of life, and molecular markers (CALGB 9481). J Clin Oncol 24 9 (2006) 1395-1403
42. Fiorentini G., Cantore M., Rossi S., et al. Hepatic arterial chemotherapy in combination with systemic chemotherapy compared with hepatic arterial chemotherapy alone for liver metastases from colorectal cancer: results of a multi-centric randomized study. In Vivo 20 6A (2006) 707-709
43. Kemeny N., Gonen M., Sullivan D., et al. Phase I study of hepatic arterial infusion of floxuridine and dexamethasone with systemic irinotecan for unresectable hepatic metastases from colorectal cancer. J Clin Oncol 19 10 (2001) 2687-2695
44. Kemeny N., Jarnagin W., Paty P., et al. Phase I trial of systemic oxaliplatin combination chemotherapy with hepatic arterial infusion in patients with unresectable liver metastases from colorectal cancer. J Clin Oncol 23 22 (2005) 4888-4896
45. Kemeny N., and Fong Y. Treatment of liver metastases. In: Kufe D.W., Pollock R.E., Weichselbaum R.R., et al. (Eds). Cancer medicine vol. 2 (2003), B.C. Decker, Lewiston (NY) 1555-1567
46. Gluck W.L., Akwari O.E., Kelvin F.M., et al. A reversible enteropathy complicating continuous hepatic artery infusion chemotherapy with 5-fluoro-2-deoxyuridine. Cancer 56 10 (1985) 2424-2427
47. Kemeny N., and Atiq O. Intrahepatic chemotherapy for metastatic colorectal cancer. In: Markman M. (Ed). Regional chemotherapy: clinical research and practice (2000), Humana Press, Inc.,, Totowa (NJ) 5-19
48. Northover J.M., and Terblanche J. A new look at the arterial supply of the bile duct in man and its surgical implications. Br J Surg 66 6 (1979) 379-384
49. Kemeny N., Seiter K., Niedzwiecki D., et al. A randomized trial of intrahepatic infusion of fluorodeoxyuridine with dexamethasone versus fluorodeoxyuridine alone in the treatment of metastatic colorectal cancer. Cancer 69 2 (1992) 327-334
50. Stagg R.J., Venook A.P., Chase J.L., et al. Alternating hepatic intra-arterial floxuridine and fluorouracil: a less toxic regimen for treatment of liver metastases from colorectal cancer. J Natl Cancer Inst 83 6 (1991) 423-428
51. Kemeny N., Cohen A., Bertino J.R., et al. Continuous intrahepatic infusion of floxuridine and leucovorin through an implantable pump for the treatment of hepatic metastases from colorectal carcinoma. Cancer 65 11 (1990) 2446-2450
52. Kemeny N., Conti J.A., Cohen A., et al. Phase II study of hepatic arterial floxuridine, leucovorin, and dexamethasone for unresectable liver metastases from colorectal carcinoma. J Clin Oncol 12 11 (1994) 2288-2295